Vedanta Biosciences, Inc.
CAGE Code: 6DGY3
NCAGE Code: 6DGY3
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 968063102
Summary
Vedanta Biosciences, Inc. is an Active Commercial Supplier with the Cage Code 6DGY3 and is tracked by Dun & Bradstreet under DUNS Number 968063102..
Address
19 Blackstone St
Cambridge MA 02139-3709
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Course Technology Inc Air/Liquid America Specialty Building Services Avery And Saul Co Inc Moldyn Inc Advanced Position Systems Inc. Bbn Planet Corp Northeast Scientific Corp Forrester Research Inc Ruffcorn Fastener Co Quantum Energy Technologies Corp International Integration Voltaris, Llc Heritage Resource Group, Inc. National Bureau Of Economic Research Cellxicus, Inc. Pegasus Communiations Inc Altus Pharmaceuticals Inc. Polaroid Express Minnesota State Colleges &
Frequently Asked Questions (FAQ) for CAGE 6DGY3
- What is CAGE Code 6DGY3?
- 6DGY3 is the unique identifier used by NATO Organizations to reference the physical entity known as Vedanta Biosciences, Inc. located at 19 Blackstone St, Cambridge MA 02139-3709, United States.
- Who is CAGE Code 6DGY3?
- 6DGY3 refers to Vedanta Biosciences, Inc. located at 19 Blackstone St, Cambridge MA 02139-3709, United States.
- Where is CAGE Code 6DGY3 Located?
- CAGE Code 6DGY3 is located in Cambridge, MA, USA.
Contracting History for CAGE 6DGY3 Most Recent 25 Records
- 75A50120C00177
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- 26 May 2022
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $31,146,088.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00177
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- 10 Nov 2021
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $31,146,088.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00177
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- 7 Apr 2023
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $36,146,088.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00177
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- 27 Feb 2023
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $36,146,088.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00177
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- 13 Sep 2022
- Eo14042 To Develop Medical Countermeasures (Mcms) That Treat Antibiotic Resistant Infections.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $36,146,088.00
- Department Of Health And Human Services (Hhs)